Detalhe da pesquisa
1.
FGF-23 and sclerostin in serum and bone of CKD patients.
Clin Nephrol
; 99(5): 209-218, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970967
2.
Treatment of bone loss in CKD5D: Better survival in patients with non-high bone turnover.
Clin Nephrol
; 98(5): 219-228, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200936
3.
Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis.
J Am Soc Nephrol
; 27(8): 2475-86, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26701977
4.
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
Kidney Int
; 90(4): 828-34, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528549
5.
Diagnosis of low bone mass in CKD-5D patients.
Clin Nephrol
; 85(2): 77-83, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26587778
6.
Coronary artery calcification in CKD-5D patients is tied to adverse cardiac function and increased mortalityâ©.
Clin Nephrol
; 86 (2016)(12): 291-302, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27805564
7.
High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.
J Am Soc Nephrol
; 26(10): 2534-44, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25838468
8.
Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Am J Kidney Dis
; 66(1): 99-105, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25843703
9.
CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.
J Am Soc Nephrol
; 25(8): 1760-73, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578135
10.
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
Kidney Int
; 85(1): 142-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23884339
11.
FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis.
Clin Nephrol
; 82(5): 287-95, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208316
12.
Differences in bone quality in low- and high-turnover renal osteodystrophy.
J Am Soc Nephrol
; 23(3): 525-32, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22193385
13.
Prevalence of low bone formation in untreated patients with osteoporosis.
PLoS One
; 17(7): e0271555, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853025
14.
The link between bone and coronary calcifications in CKD-5 patients on haemodialysis.
Nephrol Dial Transplant
; 26(3): 1010-5, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20709740
15.
Bone Quality in CKD Patients: Current Concepts and Future Directions - Part I.
Kidney Dis (Basel)
; 7(4): 268-277, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34395542
16.
Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions - Part II.
Kidney Dis (Basel)
; 7(5): 359-371, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34604343
17.
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years.
JBMR Plus
; 5(11): e10549, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761151
18.
Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.
Am J Kidney Dis
; 55(5): 897-906, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20347512
19.
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
Kidney Int
; 75(6): 617-25, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19129793
20.
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
J Am Soc Nephrol
; 19(2): 405-12, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18199805